Angel Biotechnology Holdings Plc (Angel) is engaged in the manufacture and supply of biologics. Angel specialises in the provision of advanced biologics (biological products); these include autologous and allogeneic cell therapy products, stem cells, cellular vaccines, specific purified natural and recombinant proteins, virus and bacteriophage. The Company supplies the biopharmaceuticals contract manufacturing sector of the biologics market and within that sector is focused on the early stage drug development work, such as chemistry, manufacturing and controls and pre-clinical studies, along ,with drug products for Phases I, II and III of clinical trials.